While these findings are preliminary because of the small sample size (n = 2), these data support the notion that FAK activity and cytoplasmic localization are increased within melanoma, thus enhancing nuclear FAK by FAK-Is would repress CDK4 expression and melanoma progression. The gene discussed is CDK4; the disease is melanoma.